Phosphorus’ at-home Covid-19 test uses OraSure’s Oragene •Dx (OGD-510) saliva collection device for the detection of SARS-CoV-2 virus. Credit: mattthewafflecat / Pixabay.

The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) to Phosphorus for its at-home saliva test for Covid-19.

Developed at Phosphorus’ CLIA laboratory in New Jersey, US, the Covid-19 test uses OraSure’s Oragene ·Dx (OGD-510) saliva collection device for the detection of SARS-CoV-2 virus.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Customers can order the test through the online checkout process at the company’s website. They will be required to complete a medical questionnaire, which will be reviewed by an independent physician for approval. Once approved, the company will ship a sample collection kit to the customer’s address.

The customers will receive test results within 72 hours, accompanied by a consultation from medical personnel.

Phosphorus has partnered with IRMS Institute for Reproductive Medicine and Science at Saint Barnabas to conduct the Covid-19 testing.

The FDA emergency use approval follows a rigorous round of validation studies, in addition to the synthetic sample performance study initially required by the agency, the company noted.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the test is the second at-home unsupervised saliva test to be approved by the FDA.

Phosphorus co-founder and CEOAlexander Bisignano said: “Covid-19 testing is essential to getting life back to normal. This test will allow people from coast to coast to be tested from the safety of their homes with the oversight of medical personnel.

“We thank the FDA for their hard work throughout this crisis and the quick action they have taken. We look forward to helping the country re-open.”

In 2017, Phosphorus introduced new genetic tests for the detection of hereditary cancers.

The company offers advanced genomic tests based on next-generation sequencing (NGS) technologies to healthcare providers and hospitals.